Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group Plc LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 78.50 77.00 80.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 159.9 11.0 10.9 7.2 67

The Mission Marketing Share Discussion Threads

Showing 1101 to 1124 of 1450 messages
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
DateSubjectAuthorDiscuss
05/8/2017
15:12
What is the poison pill here? Can't see anything at a very 1st cursory glance. What puts me off badly, before even spending a serious amount of time on this, is that management are not actively buying shares even at this very low apparent valuation. £9k over the last 12 months ish is pretty unconvincing. Heck, if I was inside the business, and I thought the business was quality, and the markets were valuing it at the low side of high-end single digits earnings, I'd be buying at EVERY opportunity, and I'm pretty sure the market would follow. That they aren't is a serious concern.
dan_the_epic
24/7/2017
14:48
finncap retains 69p target price
mfhmfh
24/7/2017
07:28
IMHO solid trading update as usual, share price unlikely to move as usual.
mfhmfh
24/7/2017
06:26
Seems to be some RNS issues today, so I'll post today's update The Mission Marketing Group plc Trading update and notice of results The Mission Marketing Group plc ('the missiontm', or "the Group" AIM: TMMG), the marketing communications and advertising group, today issues a trading update for the six months ended 30 June 2017. The Board is pleased to report that trading is in line with expectations and, for the first half of 2017, we again expect double digit growth in headline profit before tax. The Group's net debt fell £2.0m after making acquisition consideration payments totalling £3.7m in the period, reflecting strong working capital inflows. Net debt was £9.3m at 30 June 2017 and the Group's leverage ratios (the ratios of net bank debt and total debt to EBITDA) again reduced during the six month period and remain comfortably within the limits set by the Board for these key performance indicators. In common with recent years, we expect our results for the year to 31 December 2017 to again have a significant bias towards the second half and we look forward to further progress over the remainder of the year. The Group expects its interim results, for the six months ended 30 June 2017, to be announced on 21 September.
dr biotech
13/7/2017
09:30
xd today...
dr biotech
11/5/2017
13:36
This is simply much too cheap on almost all measures IMO. OK in an absolutely ideal world you'd have a ptbv discount, but given the acquisitions and the nature of the business, they're always stuffed full of intangibles. This is still way cheaper than its peers and whilst the balance sheet isn’t as strong as you'd like, it is improving - and they are VERY cheap on earnings & expect growth this year. Understandably, the Long Term Incentive Plan is unpopular but the target price for the options at 75p is kind of "N/A" AFAIAC. However, a share price of around 65pps (with a corresponding P/E of around 8 and falling) looks much more reasonable IMO; at which the anticipated yield (currently 4.2%) would be 2.77%, so still not unreasonable and only marginally behind the sector average.
gingerplant
28/4/2017
15:31
Everything we know and don't understand in that report!
red_shed2000
28/4/2017
14:22
Edison update:- http://www.edisoninvestmentresearch.com/research/report/the-mission-marketing-group22/full/ Consensus estimate forecasts:- Y/E 31/12/17 Pbt £7.9m EPS 7.3p Div 1.65p Y/E 31/12/18 Pbt £8.9m EPS 8.3p Div 1.80p
jeff h
20/4/2017
13:36
maybe, but also provided a nice reminder for me to top up!
qs99
20/4/2017
13:18
Price movements here are often spikey and random. I'm happy it's up on this occasion but I won't read anything into it.
dr biotech
20/4/2017
12:28
decent volume IMO as well
qs99
20/4/2017
12:02
well I have bought a few just in case...gla
qs99
20/4/2017
11:58
interesting spike today, despite earlier sell in IC? I wonder whether this will as it languishes be a target? DYOR
qs99
31/3/2017
19:09
Headline about the figures hiding a multitude of sins. Seems to point to lack of organic growth ( or clarity about it) I've not read the whole article though.
dr biotech
31/3/2017
09:31
Why Markie?
cliffpeat
31/3/2017
09:04
Sell recommendation in the IC
markie7
30/3/2017
15:33
As has been the pattern for some years, up on the news then down for no apparent reason in the days after. Have to wonder if this will ever breakb45 let alone 50...
dr biotech
23/3/2017
10:15
Finncap; Once again, management has demonstrated its ability to deliver consistent growth. Our two-year forecast profile implies a further 20% growth in profitability accompanied by strong cash generation. However, the stock continues to sit at a significant discount to its peers, which on a current year EV/EBITDA basis is now 38%. We raise our target price to 66p following the introduction of a 2018 forecast, implying 57% upside, which would effectively halve the peer group discount.
davebowler
23/3/2017
08:39
No hidden surprises - as we all know these were telegraphed in the IMS. Optimisitic forward looking statement though. Long term hold for me too
dr biotech
23/3/2017
08:33
Well nice results and outlook again....still holding and waiting!
red_shed2000
22/2/2017
10:45
If they get the share price to 75p they are welcome to the shares!!!
red_shed2000
22/2/2017
09:59
In a thinly traded, lowly rated company such as this a decent buyback program might even be able to create the vesting conditions (over 75p for 15 days) :-)
cockerhoop
22/2/2017
09:59
The usual problem with these schemes if that if the target is too challenging then it can actually become de-motivational (if such a word exists), as some affected parties see it as 'income' lost.
pj 1
25/1/2017
09:14
Perhaps yesterday's low was the floor. Let's hope so anyway.
dr biotech
Chat Pages: Latest  46  45  44  43  42  41  40  39  38  37  36  35  Older
ADVFN Advertorial
Your Recent History
LSE
TMMG
The Missio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201028 12:20:11